Reversible pulmonary disease and eosinophilia associated with sulphasalazine.
作者： A Jordan , R E Cowan
DOI: 10.1177/014107688808100418
关键词: Pulmonary disease 、 Internal medicine 、 Lung disease 、 Medicine 、 Sulfasalazine 、 Ulcerative colitis 、 Gastroenterology 、 Eosinophilia 、 Pulmonary Eosinophilia
摘要:
sagepub.com
sci-hub.se 参考文章(5)
JOHN R. COLLINS, Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis. Southern Medical Journal. ,vol. 61, pp. 354- 358 ,(1968) , 10.1097/00007611-196804000-00005
O. E. Eade, P. J. Whorwell, C. L. Smith, J. R. Alexander, Pulmonary function in patients with inflammatory bowel disease. The American Journal of Gastroenterology. ,vol. 73, pp. 154- 156 ,(1980)
T Higenbottam, G M Cochrane, T J Clark, D Turner, R Millis, W Seymour, Bronchial disease in ulcerative colitis. Thorax. ,vol. 35, pp. 581- 585 ,(1980) , 10.1136/THX.35.8.581
KENNETH K. WANG, BRAD A. BOWYER, C. RICHARD FLEMING, KENNETH W. SCHROEDER, Pulmonary Infiltrates and Eosinophilia Associated With Sulfasalazine Mayo Clinic Proceedings. ,vol. 59, pp. 343- 346 ,(1984) , 10.1016/S0025-6196(12)61431-1
Richard H. Moseley, Kenneth W. Barwick, Kenneth Dobuler, Vincent A. DeLuca, Sulfasalazine-induced pulmonary disease Digestive Diseases and Sciences. ,vol. 30, pp. 901- 904 ,(1985) , 10.1007/BF01309523